Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.15247 http://scihub22266oqcxt.onion/10.18632/oncotarget.15247 C5400593!5400593!28199963     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncotarget 2017 ; 8 (13): 21410-7 Nephropedia Template TP {{tp|p=28199963|t=2017. Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis |pdf=|usr=}}{{28199963}} gab.com Text Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28199963 #FOAvip Since the long non-coding RNA HULC (Highly Upregulated in Liver Cancer) is dysregulated in many cancers, we performed a meta-analysis to determine its prognostic potential in malignant tumors. We searched electronic databases, including PubMed, Medline, OVID, Cochrane Library and Web of Science from inception until August 14, 2016 and identified seven studies with 730 cancer patients for the meta-analysis. We analyzed the hazard ratios (HRs) and 95% confidence intervals (CIs) to determine the relationship between HULC expression and overall survival (OS). We also using RevMan5.3 software to calculate odds ratio (ORs) to assess the association between HULC expression and pathological parameters, including lymph node metastasis (LNM), distant metastasis (DM) and the tumor stage. Our analysis showed that higher HULC expression was associated with OS (HR= 0.50, 95% CI: 0.35?0.70, P <0.00001), LNM (OR=0.20, 95 % CI 0.06?0.64), DM (OR=0.27, 95% CI: 0.13?0.54) and the tumor stage (OR=0.39, 95 % CI 0.25?0.64). These meta-analysis data demonstrate that higher HULC expression can be a useful prognostic biomarker in human cancers. Twit Text FOAVip Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28199963 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28199963 #FOAvip English Wikipedia <ref>{{Cite pmid|28199963}}</ref> Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis #MMPMID28199963 Fan YH; Wu MJ; Jiang Y; Ye M; Lu SG; Wu L; Zhu XG Oncotarget 2017[Mar]; 8 (13): 21410-7 PMID28199963show ga Since the long non-coding RNA HULC (Highly Upregulated in Liver Cancer) is dysregulated in many cancers, we performed a meta-analysis to determine its prognostic potential in malignant tumors. We searched electronic databases, including PubMed, Medline, OVID, Cochrane Library and Web of Science from inception until August 14, 2016 and identified seven studies with 730 cancer patients for the meta-analysis. We analyzed the hazard ratios (HRs) and 95% confidence intervals (CIs) to determine the relationship between HULC expression and overall survival (OS). We also using RevMan5.3 software to calculate odds ratio (ORs) to assess the association between HULC expression and pathological parameters, including lymph node metastasis (LNM), distant metastasis (DM) and the tumor stage. Our analysis showed that higher HULC expression was associated with OS (HR= 0.50, 95% CI: 0.35?0.70, P <0.00001), LNM (OR=0.20, 95 % CI 0.06?0.64), DM (OR=0.27, 95% CI: 0.13?0.54) and the tumor stage (OR=0.39, 95 % CI 0.25?0.64). These meta-analysis data demonstrate that higher HULC expression can be a useful prognostic biomarker in human cancers. äLong non-coding RNA HULC as a potential prognostic biomarker in human (epmc).pdf DeepDyve Pubget Overpricing